You are here

Recruiting Trials: Cord Blood

This portal enables our readers to find registered clinical trials worldwide that are currently recruiting patients for therapy with cord blood stem cells. If you are a patient seeking more information about a trial, please click on the link under the trial's registry identification. That will take you to the original trial registration, and within that description you should find contact information. This list does not constitute medical advice and Parent's Guide to Cord Blood Foundation has no relationship with any of these trial sponsors. We maintain this list by checking multiple national clinical trial registries. We only display clinical studies that are registered on an official trials registry.

Contents are current through the end of 2021.

This web page was researched by Frances Verter, PhD, Alexey Bersenev, MD PhD, and Pedro Silva Couto, PhD ©2016-2022. Sources of clinical trials were searches of ClinicalTrials.gov, Chinese Clinical Trial Registry (ChiCTR), Japan University hospital Medical Information Network Clinical Trial Registry (UMIN-CTR), Japan Medical Association Clinical Trial Registry (JMA-CTR), Clinical Research Information Service from South Korea (CRiS), EU Clinical Trials Register (EudraCT), World Health Organization International Clinical Trials Registry Platform (ICTRP), Netherlands Trial Register (NTR), Australian New Zealand Clinical Trial Registry (ANZCTR), Clinical Trials Registry-India (CTRI), German Clinical Trials Register (DRKS), and Iranian Registry of Clinical Trials (IRCT).

Displaying 3 clinical trials recruiting at 3 locations.

Strokes can be ischemic or hemorrhagic. Ischemic stroke occurs when a blocked blood vessel prevents the brain from receiving oxygen and brain cells start to die. Hemorrhagic stroke occurs when a weakened blood vessel bleeds in the brain and causes injury from swelling. Studies are testing cord blood treatment for adults with stroke. Our March 2022 newsletter tells the story of a man who recovered from a stroke after a single cord blood infusion.

Trial registry Patient Ages Hospital Name
35 to 70 Liaocheng People's Hospital 
45 to 80 China Medical University Beigang Hospital
20+ Bundang CHA Medical Center